Bright Minds Biosciences ... (DRUG)
undefined
undefined%
At close: undefined
41.45
0.61%
After-hours Dec 13, 2024, 04:16 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19
Net Income -7.37M -14.96M -8.65M -480.38K -78.72K
Depreciation & Amortization 72.45K 6.04K - - -
Stock-Based Compensation 1.15M 875.06K 880.62K 161.30K -
Other Working Capital -941.72K 771.94K 416.23K 30.68K 36.71K
Other Non-Cash Items 65.10K -229.57K 144.76K 161.30K 110.12K
Deferred Income Tax - - - - -
Change in Working Capital -941.72K 726.31K 306.08K 30.68K 36.71K
Operating Cash Flow -7.02M -13.59M -7.32M -288.39K -42.01K
Capital Expenditures 5.00 - - - -
Acquisitions - - - - -
Purchase of Investments - - - - -
Sales Maturities Of Investments - - - - -
Other Investing Acitivies - - - - -
Investing Cash Flow - - - - -
Debt Repayment -86.11K -7.16K - - -
Common Stock Repurchased - - - - -
Dividend Paid - - - - -
Other Financial Acitivies 1.06M 1.17M -1.69M - 366.00K
Financial Cash Flow 2.19M 5.20M 26.06M 1.01M 122.00K
Net Cash Flow -4.88M -8.13M 18.96M 719.94K 79.99K
Free Cash Flow -7.02M -13.59M -7.32M -288.39K -42.01K